AKT1 and nasopharyngeal carcinoma: BRD7 was confirmed to be down‐expressed in NPC and acts as a tumour suppressor in NPC by negatively regulating signalling pathways like ERK, Rb/E2F and PI3K/AKT, thereby inhibiting tumour progression and metastasis.4, 5, 6, 7